Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 501–600 of 1,004
TCF7L2 splice variants have distinct effects on β-cell turnover and function
Bacquer, O. L., Shu, L., Marchand, M., Neve, B., Paroni, F., Kerr-Conte, J., Pattou, F. N., Froguel, P., & Maedler, K. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr072 · Cited by 79
Research Resource: The Pdx1 Cistrome of Pancreatic Islets
Khoo, C., Yang, J., Weinrott, S. A., Kaestner, K. H., Naji, A., Schug, J., & Stoffers, D. A. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1231 · Cited by 76
“TCF7L2 is a Wnt signaling mediator with single nucleotide polymorphisms strongly associated with type 2 diabetes (49, 50).”
BackgroundBone metabolism and fracture risk in type 2 diabetes mellitus [Review]
Yamaguchi, T., & Sugimoto, T. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0063 · Cited by 70
Wnt/β-catenin signaling in bone marrow niche
Ahmadzadeh, A., Norozi, F., Shahrabi, S., Shahjahani, M., & Saki, N. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2300-y · Cited by 83
Stančáková, A., & Laakso, M. (2016) · Endocrine development · doi:10.1159/000439418 · Cited by 82
Xiang, X., Cai, H.-D., Su, S., Dai, X., Zhu, K. Y., Guo, J., Yan, H., Guo, S., Gu, W., Qian, D., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.030 · Cited by 71
Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight
Galijatovic, E. A. A., Pilgaard, K. A., Pisinger, C. H., Harder, M. N., Grarup, N., Færch, K., Poulsen, P., Witte, D. R., Jørgensen, T., Vaag, A. A., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1790-0 · Cited by 78
Zhao, J., & Grant, S. F. A. (2011) · Journal of Obesity · doi:10.1155/2011/845148 · Cited by 93
“In addition, a cohort of African ancestry in many instances can aid in refining the anticipated association(s) made in with the GWAS approach due to lower LD in this ethnicity, for example, the association of T2D with TCF7L2 [116] has been refined utilizing a West African patient cohort [117].”
BackgroundSelf-citationMondal, A. K., Das, S. K., Baldini, G., Chu, W. S., Sharma, N., Hackney, O. G., Zhao, J., Grant, S. F. A., & Elbein, S. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2064 · Cited by 70
Self-citationMohan, V., & Anbalagan, V. P. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.107825 · Cited by 85
“%) as T2DM.”
BackgroundInfluentialType 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes
Andersen, M. K., Sterner, M., Forsén, T., Käräjämäki, A., Rolandsson, O., Forsblom, C. M., Groop, P., Lahti, K., Nilsson, P. M., Groop, L., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3287-8 · Cited by 78
“In Europeans, the intronic TCF7L2 rs7903146 variant is the strongest identified genetic risk factor for type 2 diabetes [22].”
BackgroundPharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Florez, J. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4227-1 · Cited by 78
“Discovered in 2006 as a gene containing a common intronic variant with a relatively strong effect on type 2 diabetes risk [43], it was not until 2010 that fine-mapping and functional studies conclusively proved that the rs7903146 variant was causal in influencing TCF7L2 expression in islets [44], although a recent rep…”
BackgroundRoach, J. C., Deutsch, K., Li, S., Siegel, A. F., Bekris, L. M., Einhaus, D., Sheridan, C. M., Glusman, G., Hood, L., Lernmark, Å., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507876 · Cited by 75
β‐cell mass in people with type 2 diabetes
Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69
Alanazi, M. S., Parine, N. R., Shaik, J. P., Alabdulkarim, H. A., Ajaj, S. A., & Khan, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059555 · Cited by 70
Ren, Q., Han, X., Wang, F., Zhang, X. Y., Han, L., Luo, Y., Zhou, X., & Ji, L. (2008) · Diabetologia · doi:10.1007/s00125-008-1039-3 · Cited by 69
“In those studies, the frequency of risk alleles (rs7903146 and rs12255372) were found to be more prevalent in non-Asian populations (MAF=0.250– Table 3 Pairwise LD coefficients D′ (below diagonal of empty cells) and r2 (above diagonal) of polymorphic sites at the TCF7L2 gene locus r2 SNP name rs7903146 rs12255372 rs38…”
BackgroundResultInfluentialFukusaki, T., Ohara, N., Hara, Y., Yoshimura, A., & Yoshiura, K.-I. (2007) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2007.00979.x · Cited by 78
The effects of aging on the expression of Wnt pathway genes in mouse tissues
Hofmann, J. W., McBryan, T., Adams, P. D., & Sedivy, J. M. (2014) · AGE · doi:10.1007/s11357-014-9618-3 · Cited by 75
“2005), Alzheimer’s disease, and Parkinson’s disease (Berwick and Harvey 2012); increased Wnt signaling with age is thought to cause fibrosis in skeletal muscle, resulting in sarcopenia (Arthur and Cooley 2012); and a variant of TCF7L2, a transcriptional effector of the Wnt pathway, increases the risk of type II diabet…”
BackgroundWabitsch, M., Lahr, G., van de Bunt, M., Marchant, C., Lindner, M. S., Puttkamer, J. V., Fenneberg, A., Debatin, K., Klein, R., Ellard, S., et al. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02285.x · Cited by 69
The search for putative unifying genetic factors for components of the metabolic syndrome
Sjögren, M., Lyssenko, V., Jonsson, A. E., Berglund, G., Nilsson, P. M., Groop, P., & Orho‐Melander, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1151-4 · Cited by 79
“Four of the selected single nucleotide polymorphisms (SNPs) had been identified earlier in candidate gene or linkage studies and convincingly replicated (TCF7L2, PPARG, KCNJ11 and WFS1) [9, 11–13].”
BackgroundThe Role of De Novo Noncoding Regulatory Mutations in Neurodevelopmental Disorders
Turner, T. N., & Eichler, E. E. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.11.002 · Cited by 69
Central Regulation of Glucose Homeostasis
Tups, A., Benzler, J., Sergi, D., Ladyman, S. R., & Williams, L. M. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c160015 · Cited by 63
Savcheniuk, O., Virchenko, O., Falalyeyeva, T. M., Beregova, T. V., Babenko, L. P., Lazarenko, L. M., Demchenko, O. M., Bubnov, R. V., & Spivak, M. Y. (2014) · The EPMA Journal · doi:10.1186/1878-5085-5-2 · Cited by 76
“There are currently 22 gene associations supported by positive studies [52-54].”
BackgroundAnalysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations
Nejentsev, S., Thye, T., Szeszko, J. S., Stevens, H. E., Balabanova, Y., Chinbuah, A., Hibberd, M. L., van de Vosse, E., Alisjahbana, B., van Crevel, R., et al. (2008) · Nature Genetics · doi:10.1038/ng0308-261 · Cited by 70
Melatonin receptor 1 B polymorphisms associated with the risk of gestational diabetes mellitus
Kim, J. Y., Cheong, H. S., Park, B.-L., Baik, S. H., Park, S., Lee, S. W., Kim, M.-H., Chung, J. H., Choi, J. S., Kim, M.-Y., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-82 · Cited by 68
“Previously, there have been a few cases where a gene associated with T2DM was not associated with GDM at all [20], or showed different effect sizes [21,22], and our results suggest that MTNR1B affects T2DM and GDM in varying degrees as well.”
ResultYu, M., Xu, X.-J., Yin, J., Wu, J., Chen, X., Gong, Z.-C., Ren, H.-Y., Huang, Q., Sheng, F.-F., Zhou, H.-H., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.242 · Cited by 68
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., Gilbert, E. R., & Liu, D. (2012) · Current Diabetes Reviews · doi:10.2174/15733998130104 · Cited by 511
The Classification and Diagnosis of Diabetes Mellitus
Alberti, K. G. M. M. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch2 · Cited by 79
Morgan, A. R., Thompson, J., Murphy, R., Black, P., Lam, W.-J., Ferguson, L. R., & Mitchell, E. A. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-125 · Cited by 79
“TCF7L2 10 Type 2 Diabetes Fine-mapping of linkage peak [38,55,56] rs7903146 Intronic”
BackgroundHansson, O., Zhou, Y., Renström, E., & Osmark, P. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0149-8 · Cited by 67
Martínez-Gómez, L. E., Cruz, M., Martínez‐Nava, G. A., Madrid‐Marina, V., Parra, E. J., García-Mena, J., Espinoza-Rojo, M., Estrada-Velasco, B. I., Piza-Roman, L. F., Aguilera, P., et al. (2011) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2011.00668.x · Cited by 75
Type 2 diabetes and obesity: genomics and the clinic
Travers, M. E., & McCarthy, M. I. (2011) · Human Genetics · doi:10.1007/s00439-011-1023-8 · Cited by 77
Progress in genetics of type 2 diabetes and diabetic complications
Shojima, N., & Yamauchi, T. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13970 · Cited by 78
“An association study on chromosome 10q, which has been mapped as the type 2 diabetes locus, identified variants in TCF7L2 (T cell factor like 2).(40) In 2007, the first GWAS for type 2 diabetes included thousands of participants and identified 10 genomic loci.”
Garagnani, P., Giuliani, C., Pirazzini, C., Olivieri, F., Bacalini, M. G., Ostan, R., Mari, D., Passarino, G., Monti, D., Bonfigli, A. R., et al. (2013) · Aging · doi:10.18632/aging.100562 · Cited by 66
Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury
Adhikari, N., Charles, N. J., Lehmann, U., & Hall, J. L. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0081-1 · Cited by 69
“Interestingly, recent work from the field of genetics suggests that a variant in the gene that encodes Tcf-4 (TCF7L2) confers risk of type 2 diabetes [ 43 ].”
BackgroundCentralized Biorepositories for Genetic and Genomic Research
Ginsburg, G. S. (2008) · JAMA · doi:10.1001/jama.299.11.1359 · Cited by 66
The Role of Vascular Cells in Pancreatic Beta-Cell Function
Burganova, G., Bridges, C. A., Thorn, P., & Landsman, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667170 · Cited by 73
“Polymorphism in TCF7L2 (TCF4) strongly correlates with an increased risk of type 2 diabetes (91).”
BackgroundCellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
Phang, R. J., Ritchie, R. H., Hausenloy, D. J., Lees, J. G., & Lim, S. Y. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac049 · Cited by 72
“Within the coronary vasculature, endothelial cells form a continuous semipermeable biological membrane that regulates the Figure 2 Cellular interactions among non-myocytes in the heart and their pathological phenotypes in T2DM.”
BackgroundInfluentialDokmanovic-Chouinard, M., Chung, W. K., Chèvre, J.-C., Watson, E., Yonan, J., Wiegand, B., Bromberg, Y., Wakae, N., Wright, C. V. E., Overton, J. D., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000137 · Cited by 76
“PPARG, CAPN10), and a recent series of genome-wide association studies of large numbers of well-phenotyped subjects [25,26,27,28,29,30,31] have identified T2D susceptibility loci/genes (e.”
BackgroundImpact of TCF7L2 rs7903146 on Insulin Secretion and Action in Young and Elderly Danish Twins
Wegner, L., Hussain, M. S., Pilgaard, K., Hansen, T., Pedersen, O., Vaag, A., & Poulsen, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0855 · Cited by 65
“Several studies suggest that defects in the enteroinsular axis mediate the diabetogenic effects of TCF7L2 (8, 33).”
Backgroundβ-Catenin Links Hepatic Metabolic Zonation with Lipid Metabolism and Diet-Induced Obesity in Mice
Behari, J., Li, H., Liu, S., Stefanovic-Racic, M., Alonso, L., O'Donnell, C. P., Shiva, S., Singamsetty, S., Watanabe, Y., Singh, V. P., et al. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.08.022 · Cited by 65
TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes
Redondo, M. J., Geyer, S., Steck, A. K., Sosenko, J., Anderson, M., Antinozzi, P., Michels, A., Wentworth, J., Xu, P., Pugliese, A., et al. (2018) · Diabetes Care · doi:10.2337/dc17-0961 · Cited by 63
“3%, respectively, of the individuals with type 2 diabetes (3).”
Genetic architecture of type 2 diabetes
Hara, K., Shojima, N., Hosoe, J., & Kadowaki, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.012 · Cited by 76
Principles and Practice of Nonpharmacological Interventions to Reduce Cardiometabolic Risk
Dagogo-Jack, S. E., Egbuonu, N., & Edeoga, C. (2010) · Medical Principles and Practice · doi:10.1159/000285280 · Cited by 71
“Furthermore, a microsatel- lite within intron 3 of the transcription factor 7-like 2 (TCF7L2) gene, located on chromosome 10q, has been strongly associated with type 2 diabetes [”
BackgroundGenetics of Gestational Diabetes Mellitus and Type 2 Diabetes
Watanabe, R. M., Black, M. H., Xiang, A. H., Allayee, H., Lawrence, J. M., & Buchanan, T. A. (2007) · Diabetes Care · doi:10.2337/dc07-s205 · Cited by 67
Future Use of Genomics in Coronary Artery Disease
Damani, S. B., & Topol, E. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.062 · Cited by 76
Molecular Genetic Regulation of Slc30a8/ZnT8 Reveals a Positive Association With Glucose Tolerance
Mitchell, R. K., Hu, M., CHABOSSEAU, P. L., Cane, M. C., Meur, G., Bellomo, E. A., Carzaniga, R., Collinson, L., Li, W.-H., Hodson, D. J., et al. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1227 · Cited by 70
“In the light of the present results, the possibility that other GWAS genes expressed in multiple tissues, eg, TCF7L2 (42, 43), might act via extrapancreatic sites to regulate insulin secretion, would seem worthy of careful investigation.”
BackgroundInfluentialFreimer, N. B., & Sabatti, C. (2007) · Nature · doi:10.1038/nature05568 · Cited by 70
Effect of Type 2 Diabetes Predisposing Genetic Variants on Colorectal Cancer Risk
Sáinz, J., Rudolph, A., Hoffmeister, M., Frank, B., Brenner, H., Chang-Claude, J. C., Hemminki, K., & Försti, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2565 · Cited by 71
“Given that the TCF7L2_rs7903146 SNP has previously been associated with T2D, reduced -cell function, and insulin secretion (10, 11), and that TCF7L2 acts in the Wnt signaling cascade (12), a pathway known to be involved in colorectal carcinogenesis, this variant may modulate the CRC risk through one or more of these m…”
BackgroundFurukawa, Y., Shimada, T., Furuta, H., Matsuno, S., Kusuyama, A., Doi, A., Nishi, M., Sasaki, H., Sanke, T., & Nanjo, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1029 · Cited by 69
Corella, D., Coltell, Ó., Sorlí, J. V., Estruch, R., Quiles, L., Martínez‐González, M. Á., Salas‐Salvadó, J., Castañer, O., Arós, F., Ortega‐Calvo, M., et al. (2016) · Nutrients · doi:10.3390/nu8120793 · Cited by 66
Figeac, F., Uzan, B., Faro, M., Chelali, N., Portha, B., & Movassat, J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00538.2009 · Cited by 75
Islet Specific Wnt Activation in Human Type II Diabetes
Lee, S. H., Demeterco, C., Geron, I., Abrahamsson, A. E., Levine, F., & Itkin‐Ansari, P. (2008) · Journal of Diabetes Research · doi:10.1155/2008/728763 · Cited by 71
“Stabilized β-catenin translocates into the nucleus where it interacts with transcription factors of the TCF family to activate target genes, including c-myc and cyclin D family members.”
BackgroundMethodInfluentialBaldassano, R. N., Bradfield, J. P., Monos, D. S., Kim, C. E., Glessner, J., Casalunovo, T., Frackelton, E. C., Otieno, F. G., Kanterakis, S., Shaner, J. L., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.04.024 · Cited by 63
Self-citationPrevention and Treatment of Type 2 Diabetes in Youth
Libman, I. M., & Arslanian, S. A. (2006) · Hormone Research in Paediatrics · doi:10.1159/000095981 · Cited by 83
Epigenome-wide association study of adiposity and future risk of obesity-related diseases
Campanella, G., Gunter, M. J., Polidoro, S., Krogh, V., Palli, D., Panico, S., Sacerdote, C., Tumino, R., Fiorito, G., Guarrera, S., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0064-7 · Cited by 77
“Alterations in the Wnt/β-catenin pathway have been associated with obesity-related disorders such as insulin resistance and type 2 diabetes [49, 50] and FGF18 interacts with PI3K/mTOR and growth factor signalling pathways.”
BackgroundAllen, H. L., & Weedon, M. N. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01895.x · Cited by 72
Rottner, A. K., Ye, Y., Navarro‐Guerrero, E., Rajesh, V., Pollner, A., Bevacqua, R. J., Yang, J., Spigelman, A. F., Baronio, R., Bautista, A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01261-2 · Cited by 69
Gene???environment interactions in the pathogenesis of type 2 diabetes and metabolism
Grarup, N., & Andersen, G. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3281e2c9ab · Cited by 62
Li, X., Shan, J., Chang, W., Kim, I., Bao, J., Lee, H.-J., Zhang, X., Samuel, V. T., Shulman, G. I., Liu, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205015109 · Cited by 63
“One of the β-catenin–associated transcription factors, TCF7L2, was identified as a type 2 diabetes susceptibility gene by genome-wide association studies (24, 25).”
BackgroundRoswall, N., Ängquist, L. H., Ahluwalia, T. S., Romaguera, D., Larsen, S. C., Østergaard, J. N., Halkjær, J., Vimaleswaran, K. S., Wareham, N. J., Bendinelli, B., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.089706 · Cited by 70
Zimdahl, H., Ittrich, C., Graefe‐Mody, U., Boehm, B. O., Mark, M., Woerle, H., & Dugi, K. A. (2014) · Diabetologia · doi:10.1007/s00125-014-3276-y · Cited by 69
“The risk of developing diabetes is twice as high in homozygous TCF7L2 risk variant (rs7903146) carriers (TT) compared with non-risk carriers (CC) [7, 8].”
BackgroundPersonalized Nutrition and Cardiovascular Disease Prevention: From Framingham to PREDIMED
Konstantinidou, V., Daimiel, L., & Ordovás, J. M. (2014) · Advances in Nutrition · doi:10.3945/an.113.005686 · Cited by 76
Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes
Narayan, K. M. V., & Weber, M. B. (2009) · New England Journal of Medicine · doi:10.1056/nejmc082624 · Cited by 61
Is Genetic testing useful to predict type 2 diabetes?
Vassy, J. L., & Meigs, J. B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.002 · Cited by 77
Recent advances in exploring the genetic susceptibility to diabetic neuropathy
Politi, C., Ciccacci, C., D’Amato, C., Novelli, G., Borgiani, P., & Spallone, V. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.08.006 · Cited by 63
Genome-wide searching of rare genetic variants in WTCCC data
Feng, T., & Zhu, X. (2010) · Human Genetics · doi:10.1007/s00439-010-0849-9 · Cited by 64
Genes and type 2 diabetes mellitus
Groop, L., & Lyssenko, V. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0033-y · Cited by 71
Leslie, R. D., & Cohen, R. M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300403 · Cited by 67
Khor, C. C., Dávila, S., Shimizu, C., Sheng, S., Matsubara, T., Suzuki, Y., Newburger, J. W., Baker, A., Burgner, D. P., Breunis, W. B., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.086611 · Cited by 63
“For meta-analysis, data from all three cohorts were pooled and common odds ratios (ORs) across all individuals were calculated using the inverse variance method.”
MethodDetecting the Genetic Signature of Natural Selection in Human Populations: Models, Methods, and Data
Hancock, A. M., & Rienzo, A. D. (2008) · Annual Review of Anthropology · doi:10.1146/annurev.anthro.37.081407.085141 · Cited by 71
Wang, X.-F., Lin, X., Li, D.-Y., Zhou, R., Greenbaum, J., Chen, Y.-C., Zeng, C.-P., Peng, L.-P., Wu, K.-H., Ao, Z.-X., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.07.044 · Cited by 59
González‐Sánchez, J. L., Martínez-Larrad, M. T., Aben, K. K. H., Pérez‐Barba, M., & Serrano‐Ríos, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1129-2 · Cited by 60
“[2] suggested that two SNPs be analysed for replication of their finding in other populations.”
BackgroundGrant, S. F. A., Hakonarson, H., & Schwartz, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0029 · Cited by 60
“Raj et al. (84) subsequently went further by testing 12 T2D-associated gene regions in T1D, namely PPARG, CDKAL1,HNF1B,WFS1,SLC30A8,CDKN2A–CDKN2B, IGF2BP2, KCNJ11, TCF7L2, FTO, HHEX–IDE, and THADA.”
BackgroundInfluentialSelf-citationAksit, M. A., Pace, R. G., Vecchio-Pagán, B., Ling, H., Rommens, J. M., Boëlle, P., Guillot, L., Raraigh, K. S., Pugh, E., Zhang, P., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz102 · Cited by 70
Genetic and biochemical pathways of β‐cell failure in type 2 diabetes
Talchai, C., Lin, H. V., Kitamura, T., & Accili, D. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01115.x · Cited by 63
Biyasheva, A., Legro, R. S., Dunaif, A., & Urbanek, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1664 · Cited by 60
Murdolo, G., Bartolini, D., Tortoioli, C., Piroddi, M., Iuliano, L., & Galli, F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.007 · Cited by 62
Zheng, X., Ren, W., Zhang, S., Liu, J., Li, S., Li, J., Yang, P., He, J., Su, S., & Li, P. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0705-6 · Cited by 60
Winnier, D. A., Fourcaudot, M. J., Norton, L., Abdul‐Ghani, M. A., Hu, S. L., Farook, V. S., Coletta, D. K., Kumar, S., Puppala, S., Chittoor, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119941 · Cited by 63
Will Genomics Widen or Help Heal the Schism Between Medicine and Public Health?
Khoury, M. J., GWINN, M. L., Burke, W., Bowen, S. M., & Zimmern, R. L. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.05.010 · Cited by 67
Huertas‐Vázquez, A., Plaisier, C. L., Weissglas‐Volkov, D., Sinsheimer, J. S., Canizales‐Quinteros, S., Cruz‐Bautista, I., Nikkola, E., Herrera-Hernández, M. F., Dávila-Cervantes, A., Tusié‐Luna, T., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0850-6 · Cited by 59
“We tested whether the TCF7L2 variants, rs7903146 and rs12255372, previously associated with type 2 diabetes [1], also contribute to the FCHL component traits and glucose levels in Mexicans with FCHL.”
BackgroundHodgson, S., Huang, Q. Q., Sallah, N., Griffiths, C., Newman, W. G., Trembath, R. C., Wright, J., Lumbers, R. T., Kuchenbaecker, K. B., van Heel, D. A., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003981 · Cited by 64
“For example, we observed shared causal variants at the TCF7L2 locus, one of the known loci with the strongest association with T2D, and at the KCNJ11 locus, which is the target gene for drugs such as Glyburide [41,42].”
BackgroundRasche, A., Al‐Hasani, H., & Herwig, R. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-310 · Cited by 71
“However, at present only a few genes have been identified through GWA in humans [5-11].”
BackgroundAssociation of TCF7L2 Gene Polymorphisms with T2DM in the Population of Hyderabad, India
Kommoju, U. J., Maruda, J., Samy, S. K., Prasad, K. J., Irgam, K., Velaga, L., & Reddy, B. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060212 · Cited by 58
“S populations [3].”
ResultInfluentialRole of developmental transcription factors in white, brown and beige adipose tissues
Hilton, C., Karpe, F., & Pinnick, K. E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.02.003 · Cited by 68
Adeyemo, A., Ayele, F. T., Doumatey, A. P., Bentley, A. R., Chen, G., Huang, H., Zhou, J., Shriner, D., Fasanmade, O. A., Okafor, G., et al. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00335 · Cited by 65
“Notably, an African sample from the AADM study was instrumental to the refinement of the TCF7L2 locus after its initial discovery (Grant et al., 2006; Helgason et al., 2007).”
MethodKarczewska‐Kupczewska, M., Stefanowicz, M., Matulewicz, N., Nikołajuk, A., & Strączkowski, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1594 · Cited by 62
Regulation of Osteoblast Metabolism by Wnt Signaling
Moorer, M. C., & Riddle, R. C. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.3.318 · Cited by 59
Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management
Chi, T., Lin, J., Wang, M., Zhao, Y., Liao, Z., & Wei, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.630032 · Cited by 62
“The first GWAS (61) repeated the previously known correlation between TCF7L2 and type 2 diabetes, which has been found in Icelandic populations (63).”
Dietary Effects on Incretin Hormone Secretion
Wu, T., Rayner, C. K., Jones, K. L., & Horowitz, M. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00003-5 · Cited by 62
“The diabetes-related transcription factor 7-like 2 (TCF7L2) gene was the first candidate proposed to affect GLP-1 secretion due to its influence on intestinal proglucagon gene expression (Grant et al., 2006), although the principle effect of TCF7L2 is on the pancreatic islets themselves (Schafer et al.”
BackgroundSchadt, E. E., Zhang, B., & Zhu, J. (2009) · Genetica · doi:10.1007/s10709-009-9359-x · Cited by 60
“…(Edwards et al. 2005; Haines et al. 2005; Klein et al. 2005), heart disease (Helgadottir et al. 2007; McPherson et al. 2007), host control of HIV-1(Fellay et al. 2007), type I and II diabetes (Grant et al. 2006; Sladek et al. 2007), and obesity (Herbert et al. 2006), to name just a few.”
BackgroundLiu, P., Chang, Y., Jiang, Y., Chen, W. J., Chang, T., Kuo, S., Lee, K., Hsiao, P., Chiu, K. C., & Chuang, L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0609 · Cited by 63
Prime suspect: the TCF7L2 gene and type 2 diabetes risk
Hattersley, A. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33077 · Cited by 66
Delgado‐Lista, J., Pérez‐Martínez, P., García‐Ríos, A., Phillips, C. M., Williams, C. M., Gulseth, H. L., Helal, O., Blaak, E. E., Kiec-Wilk, B., Basu, S., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.027 · Cited by 57
Zhu, Z., Tong, X., Zhu, Z., Liang, M., Cui, W., Su, K., Li, M. D., & Zhu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061943 · Cited by 61
“For L3MBTL3 and RUNX1, although we failed to identify any report of their involvement in T2D, they have been shown to interact with TCF7L2 indirectly at the protein level.”
BackgroundInfluentialParton, L. E., McMillen, P. J., Shen, Y., Docherty, E., Sharpe, E., Diraison, F., Briscoe, C. P., & Rutter, G. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00067.2006 · Cited by 57
“Likewise, expression of transcription factor 7-like 2, TCF7L2 (formerly termed TCF-4), a transcription factor recently linked to increased susceptibility to T2D in humans (22), was increased in ZDF islets, a change again unaffected by blockade of SREBP-1c.”
BackgroundKaraderi, T., Drong, A., & Lindgren, C. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0648-8 · Cited by 67
TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes
Shah, M., Varghese, R. T., Miles, J. M., Piccinini, F., Dalla Man, C., Cobelli, C., Bailey, K. R., Rizza, R. A., & Vella, A. (2016) · Diabetes · doi:10.2337/db15-1233 · Cited by 57
“The possibility that TCF7L2 predisposes to diabetes through effects on GLP-1 secretion was raised at the time of association of this locus with diabetes (40).”
BackgroundYadav, D. K., Shrestha, S., Lillycrop, K. A., Joglekar, C. V., Pan, H., Holbrook, J. D., Fall, C. H. D., Yajnik, C. S., & Chandak, G. R. (2017) · Epigenomics · doi:10.2217/epi-2017-0102 · Cited by 60
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.